NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
This FOA provides additional support to SBIR/STTR Phase II grantees for the validation and commercialization of methods that either replace or reduce the number of animals (referred to as alternative test methods) used in in vivo toxicology screening and testing requirements set forth by US federal government agencies.
General information about this opportunity
Last Known Status
Active
Program Number
RFA-ES-15-016 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: National Institutes of Health
Type(s) of Assistance Offered
Cooperative Agreement Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. What is the process for applying and being award this assistance?
Deadlines
11/13/2017 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-15-016.html
E-mail Address
FBOWebmaster@OD.NIH.GOV
Financial Information
Obligations
$3,000,000.00 Range and Average of Financial Assistance
Awards up to $1,000,000.00
